Clinical Psychologist | Ketamine-Assisted Psychotherapy (KAP) | LGBTQ-Affirming Therapy | Washington, DC
Dr. Matthew Schottland, PsyD is a clinical psychologist in Washington, DC with more than 15 years of experience providing individual and couples psychotherapy. At Washington Interventional Psychiatry, he works with patients pursuing ketamine-assisted psychotherapy (KAP) as part of a thoughtful and integrative approach to mental health care.
Dr. Schottland received his Doctor of Psychology (PsyD) from The Wright Institute in Berkeley, California, and completed his pre-doctoral internship at the University of Michigan Counseling and Psychological Services.
In his clinical work, Dr. Schottland takes an active and collaborative approach to psychotherapy, helping patients better understand their experiences while fostering personal agency and emotional insight. He works with individuals and couples experiencing depression, anxiety, relationship challenges, trauma, and major life transitions.
Ketamine-Assisted Psychotherapy (KAP)
Dr. Schottland has specialized training in ketamine-assisted psychotherapy (KAP) through the Ketamine Training Center. In this role, he helps patients prepare for and integrate ketamine therapy experiences, supporting the therapeutic process before and after ketamine treatment sessions.
Ketamine-assisted psychotherapy combines psychotherapy with the neurobiological effects of ketamine, helping some patients access new perspectives and emotional processing that may support lasting psychological change. Dr. Schottland works closely with the psychiatric team at Washington Interventional Psychiatry to help patients integrate insights from ketamine treatment into their broader therapeutic work.
LGBTQ-Affirming Psychotherapy
Dr. Schottland has particular experience working with LGBTQ+ individuals and couples, providing LGBTQ-affirming psychotherapy in Washington, DC. His work supports patients navigating concerns related to identity, relationships, minority stress, trauma, anxiety, depression, and life transitions.
He recognizes that LGBTQ individuals may face unique stressors, including stigma, discrimination, family conflict, and barriers to affirming mental health care. His therapeutic approach emphasizes respect, cultural humility, and a collaborative therapeutic relationship that supports each patient’s lived experience.
Interest in Psychedelic-Assisted Therapies
Dr. Schottland is also deeply interested in the emerging field of psychedelic-assisted psychotherapy, including research involving MDMA-assisted therapy and other novel treatments that may expand options for individuals struggling with depression, trauma, and other mental health conditions.
At Washington Interventional Psychiatry, Dr. Schottland works with patients across Washington, DC, Maryland, and Northern Virginia seeking ketamine-assisted psychotherapy, LGBTQ-affirming therapy, and integrative mental health care.